Altimmune
(NASDAQ:ALT)
$7.30
0.11[1.53%]
At close: May 3
$7.30
0[0.00%]
After Hours: 7:01PM EDT
Q1 2024 Earnings in 6 days from now on Thu May 9th, before the market open
Conference call scheduled in 6 days at 8:30 AM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Altimmune Stock (NASDAQ:ALT), Quotes and News Summary

Altimmune Stock (NASDAQ: ALT) stock price, news, charts, stock research, profile.

Open$7.410
Close$7.300
Volume / Avg.2.019M / 4.664M
Day Range7.190 - 7.630
52 Wk Range2.090 - 14.840
Market Cap$517.536M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest
25.21%
Days to Cover4.12

Recent News

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Deutsche Bank, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
1
Feb
1
Mar
1
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ALT
HUMA

FAQ

Q

How do I buy Altimmune (ALT) stock?

A

You can purchase shares of Altimmune (NASDAQ: ALT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Altimmune's (ALT) competitors?

A

Other companies in Altimmune’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Voyager Therapeutics (NASDAQ:VYGR).

Q

What is the target price for Altimmune (ALT) stock?

A

The latest price target for Altimmune (NASDAQ: ALT) was reported by Guggenheim on Monday, April 29, 2024. The analyst firm set a price target for 0.00 expecting ALT to fall to within 12 months (a possible -100.00% downside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Altimmune (ALT)?

A

The stock price for Altimmune (NASDAQ: ALT) is $7.3 last updated Today at May 3, 2024 at 7:01 PM EDT.

Q

Does Altimmune (ALT) pay a dividend?

A

There are no upcoming dividends for Altimmune.

Q

When is Altimmune (NASDAQ:ALT) reporting earnings?

A

Altimmune’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Altimmune (ALT) going to split?

A

There is no upcoming split for Altimmune.

Q

What sector and industry does Altimmune (ALT) operate in?

A

Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch